New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 2, 2014
10:35 EDTMYGNMyriad Genetics price target raised to $40 from $28 at Mizuho
Mizuho said the final CMS pricing for Myriad's BRCA testing represents a cut of about 20%, but that is still less severe than originally outlined. The firm raised its price target on Myriad Genetics to $40 following the ruling, but maintains its Neutral rating on the stock.
News For MYGN From The Last 14 Days
Check below for free stories on MYGN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 13, 2014
09:15 EDTMYGNOn The Fly: Pre-market Movers
Subscribe for More Information
August 12, 2014
19:02 EDTMYGNOn The Fly: After Hours Movers
Subscribe for More Information
16:11 EDTMYGNMyriad Genetics sees FY15 adjusted EPS $1.90-$2.00, consensus $2.12
Subscribe for More Information
16:10 EDTMYGNMyriad Genetics reports Q4 adjusted EPS 48c, consensus 46c
Reports Q4 revenue $188.8M, consensus $187.68M.
15:23 EDTMYGNNotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use